In recent years, GLP-1 receptor agonist injections such as semaglutide (Wegovy) or tirzepatide (Zepbound) have dominated the news as a promising medical therapy for weight loss
Our durable, compliant packaging solutions protect injection pens and vials during storage and transit while supporting branding, labeling, and regulatory requirements
Antinociceptive, hypothermic, hypotensive, and reinforcing effects of a novel neurotensin receptor agonist, NT69L, in rhesus monkeys
Increasing recognition that obesity is a chronic disease requiring long-term management makes medications like Wegovy a crucial part of treatment strategies
They may not even be sure if they want to commit to a program
Our results suggest that chlorophyllin may be a potential agent in metastatic breast cancer therapy and it needs further investigation